S80169 |
GDC-0349 |
源葉(MedMol) | ≥99% |
品牌 | 貨號 | 產(chǎn)品規(guī)格 | 價格(RMB) | 庫存(上海) | 北京 | 武漢 | 南京 | 數(shù)量 | 計量單位 | 加入購物車... |
---|---|---|---|---|---|---|---|---|---|---|
源葉(MedMol) | S80169-5mg | ≥99% | ¥850.00元 | 10 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80169-10mg | ≥99% | ¥1530.00元 | 10 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80169-25mg | ≥99% | ¥3100.00元 | 8 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80169-50mg | ≥99% | ¥4839.00元 | 7 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80169-100mg | ≥99% | ¥7739.00元 | 6 | - | - | - | EA | 加入購物車 |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3.8 nM. GDC-0349 inhibits of both mTORC1 and mTORC2 complexes.
- 靶點: mTOR:3.8 nM (Ki);mTORC1p;mTORC2;Autophagy ;PI3K;mTOR;Autophagy
- 體內(nèi)研究:
When dosed orally once daily in athymic mice in a MCF7-neo/Her2 tumor xenograft model (PI3K mutation), GDC-0349 (Compound 8h) inhibits tumor growth in a dose-dependent manner, achieving stasis (99% TGI) at the maximum tolerated dose. Body weight change is less than 10% up to the highest dose. GDC-0349 is also efficacious in other xenograft models, including PC3 (PTEN null) and 786-0 (VHL mutant). Similar levels of tumor growth inhibition are achieved when GDC-0349 is administered once every three days at higher doses compared to once every day. GDC-0349 has ~10-fold reduced free plasma clearance in both mice (100 mL/min/kg) and rats (171 mL/min/kg in rat)
- 參考文獻:
1. Pei Z, et al. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349. ACS Med Chem Lett. 2012 Nov 29;4(1):103-7.
- 溶解性: Soluble in DMSO
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.21 ml 11.049 ml 22.097 ml 5 mM 0.442 ml 2.21 ml 4.419 ml 10 mM 0.221 ml 1.105 ml 2.21 ml 50 mM 0.044 ml 0.221 ml 0.442 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)
=**